Isogenica
PrivateLast Round
VC Round
May 6, 2008
Company Overview
Isogenica operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a VC Round in May 2008.
Isogenica is a biotechnology company that operates as a contract research organization specializing in the discovery and engineering of small-format VHH single-domain antibodies for therapeutic and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isogenica Comparables
Compare Isogenica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| YUMAB GmbH | 87% | |
| Crescendo Biologics Ltd. | 82% | |
| Adimab | 82% |
For institutional investors. Book with your work email.
Isogenica Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors grew 77% MoM.
- May 2, 2025
Monthly visitors increased 32% MoM.
For institutional investors. Book with your work email.
Isogenica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Isogenica's valuation, stock price, and market status.
Is Isogenica a public or private company?
Isogenica is a private company.
What is the current stock price of Isogenica?
Isogenica is a private company, so its shares have no public market price. Caplight tracks Isogenica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Isogenica worth (valuation)?
Valuation information for Isogenica is not publicly available.
Can I buy Isogenica stock?
Isogenica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Isogenica's last funding round?
Isogenica's most recent funding round was VC Round on May 6, 2008.
Who are the main investors in Isogenica?
Investor information for Isogenica is not publicly disclosed.
Will Isogenica IPO soon?
No public IPO plans have been announced for Isogenica.
How can I track Isogenica secondary market activity?
Caplight tracks bids, offers, and trades in Isogenica's shares on secondary markets.